GateHouse Bio (fka sRNAlytics)

A bio-data company accelerating targeted therapeutics.

Company Details

Gatehouse Bio is a bio data company accelerating the development of targeted therapeutics. This is achieved through a proprietary approach using biology influenced machine learning to uncover small RNA signatures of disease. Small RNA signatures are used to discover drug targets, identify companion diagnostics and new indications for existing therapies. Our discovery engine is powered by a growing relational database of over 18,000 samples with matched sequencing data and clinical metadata. Using our platform, we’ve discovered over 1.4M small RNA genes that we believe are clinically relevant for diagnosing and subtyping disease.

Company People

Neal Foster

Neal Foster
Chief Product and Business Officer

David Salzman

David Salzman
CEO & Co-Founder

GateHouse Bio (fka sRNAlytics) News

VIEW ALL

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.